Aleglitazar, a dual peroxisome proliferator-activated...

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

Stirban, A. O., Andjelkovic, M., Heise, T., Nosek, L., Fischer, A., Gastaldelli, A., Herz, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12620
Date:
July, 2016
File:
PDF, 128 KB
english, 2016
Conversion to is in progress
Conversion to is failed